BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18335050)

  • 1. The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.
    Fukuda T; Kondo Y; Nakagama H
    PLoS One; 2008 Mar; 3(3):e1776. PubMed ID: 18335050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.
    Kashima L; Idogawa M; Mita H; Shitashige M; Yamada T; Ogi K; Suzuki H; Toyota M; Ariga H; Sasaki Y; Tokino T
    J Biol Chem; 2012 Apr; 287(16):12975-84. PubMed ID: 22337872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear localization of Chfr is crucial for its checkpoint function.
    Kwon YE; Kim YS; Oh YM; Seol JH
    Mol Cells; 2009 Mar; 27(3):359-63. PubMed ID: 19326084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHA-RING ubiquitin ligases in cell division cycle control.
    Brooks L; Heimsath EG; Loring GL; Brenner C
    Cell Mol Life Sci; 2008 Nov; 65(21):3458-66. PubMed ID: 18597043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells.
    Jiang G; Fang H; Shang X; Chen X; Cao F
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR).
    Oberoi J; Richards MW; Crumpler S; Brown N; Blagg J; Bayliss R
    J Biol Chem; 2010 Dec; 285(50):39348-58. PubMed ID: 20880844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells.
    Kim JS; Park YY; Park SY; Cho H; Kang D; Cho H
    J Biol Chem; 2011 Sep; 286(35):30615-30623. PubMed ID: 21768102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHFR: a key checkpoint component implicated in a wide range of cancers.
    Sanbhnani S; Yeong FM
    Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.
    Fu Z; Regan K; Zhang L; Muders MH; Thibodeau SN; French A; Wu Y; Kaufmann SH; Lingle WL; Chen J; Tindall DJ
    J Clin Invest; 2009 Sep; 119(9):2714-24. PubMed ID: 19690386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHFR is important for the first wave of ubiquitination at DNA damage sites.
    Liu C; Wu J; Paudyal SC; You Z; Yu X
    Nucleic Acids Res; 2013 Feb; 41(3):1698-710. PubMed ID: 23268447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.
    Kang D; Chen J; Wong J; Fang G
    J Cell Biol; 2002 Jan; 156(2):249-59. PubMed ID: 11807090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination.
    Loring GL; Christensen KC; Gerber SA; Brenner C
    Cell Cycle; 2008 Jan; 7(1):96-105. PubMed ID: 18202552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.
    Privette LM; González ME; Ding L; Kleer CG; Petty EM
    Cancer Res; 2007 Jul; 67(13):6064-74. PubMed ID: 17596595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate.
    Stavridi ES; Huyen Y; Loreto IR; Scolnick DM; Halazonetis TD; Pavletich NP; Jeffrey PD
    Structure; 2002 Jul; 10(7):891-9. PubMed ID: 12121644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOPK and PTEN participate in CHFR mediated mitotic checkpoint.
    Shinde SR; Gangula NR; Kavela S; Pandey V; Maddika S
    Cell Signal; 2013 Dec; 25(12):2511-7. PubMed ID: 24012691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction between Chfr and Kif22 controls genomic stability.
    Maddika S; Sy SM; Chen J
    J Biol Chem; 2009 May; 284(19):12998-3003. PubMed ID: 19321445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.
    Soutto M; Peng D; Razvi M; Ruemmele P; Hartmann A; Roessner A; Schneider-Stock R; El-Rifai W
    Cancer; 2010 Sep; 116(17):4033-42. PubMed ID: 20564104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chfr is required for tumor suppression and Aurora A regulation.
    Yu X; Minter-Dykhouse K; Malureanu L; Zhao WM; Zhang D; Merkle CJ; Ward IM; Saya H; Fang G; van Deursen J; Chen J
    Nat Genet; 2005 Apr; 37(4):401-6. PubMed ID: 15793587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHFR binds to and regulates MAD2 in the spindle checkpoint through its cysteine-rich domain.
    Keller JA; Petty EM
    Biochem Biophys Res Commun; 2011 Jun; 409(3):389-93. PubMed ID: 21575600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.